SLC6A3 and SLC6A3-related dopamine transporter deficiency syndrome: Together, this work provides insight into the structural mechanisms underlying DAT dysfunction and the impact of DAT dysfunction on specific behaviors, as well as on the molecular mechanisms that underlie DTDS and more broadly, PD pathology.